During the years 1992-1994, we tested 948 individuals from different population groups for HIV-1 and HIV-2 infections by ELISA and WB and for HCV infection by ELISA. Repeated ELISA reactivity for HIV was found in 2.12% of blood donors, 2.95% of fire brigade personnel and 1.61% of prisoners. Western blotting studies, however, showed that these samples were non-reactive or indeterminate to either HIV-1 or HIV-2. In contrast, anti-HCV antibodies were detected in 39% of fire brigade personnel, 31.4% of prisoners and 20.8% of blood donors. The analysis of risk factors for acquiring HCV infection showed a strong association between a past history of parenteral therapy for schistosomiasis and anti-HCV seropositivity (p < 0.0001). The implementation of preventive strategies is at the moment the mandatory choice to stop a further spread of the HCV infection. Meanwhile the same preventive measures could avoid spreading of the HIV disease.

Quinti, I., Renganathan, E., El Ghazzawi, E., Divizia, M., Sawaf, G., Awad, S., et al. (1995). Seroprevalence of HIV and HCV infections in Alexandria, Egypt. ZENTRALBLATT FUR BAKTERIOLOGIE, 283(2), 239-244.

Seroprevalence of HIV and HCV infections in Alexandria, Egypt

DIVIZIA, MAURIZIO;PANA', AUGUSTO;ROCCHI, GIOVANNI
1995-12-01

Abstract

During the years 1992-1994, we tested 948 individuals from different population groups for HIV-1 and HIV-2 infections by ELISA and WB and for HCV infection by ELISA. Repeated ELISA reactivity for HIV was found in 2.12% of blood donors, 2.95% of fire brigade personnel and 1.61% of prisoners. Western blotting studies, however, showed that these samples were non-reactive or indeterminate to either HIV-1 or HIV-2. In contrast, anti-HCV antibodies were detected in 39% of fire brigade personnel, 31.4% of prisoners and 20.8% of blood donors. The analysis of risk factors for acquiring HCV infection showed a strong association between a past history of parenteral therapy for schistosomiasis and anti-HCV seropositivity (p < 0.0001). The implementation of preventive strategies is at the moment the mandatory choice to stop a further spread of the HCV infection. Meanwhile the same preventive measures could avoid spreading of the HIV disease.
dic-1995
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/42 - IGIENE GENERALE E APPLICATA
English
Hepatitis B Surface Antigens; HIV Antibodies; Humans; Aged; Pilot Projects; HIV-1; HIV-2; Egypt; HIV Infections; Hepatitis B Antibodies; Risk Factors; Adult; Middle Aged; Hepatitis C; Hepatitis C Antibodies; Prevalence
Quinti, I., Renganathan, E., El Ghazzawi, E., Divizia, M., Sawaf, G., Awad, S., et al. (1995). Seroprevalence of HIV and HCV infections in Alexandria, Egypt. ZENTRALBLATT FUR BAKTERIOLOGIE, 283(2), 239-244.
Quinti, I; Renganathan, E; El Ghazzawi, E; Divizia, M; Sawaf, G; Awad, S; Pana', A; Rocchi, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/66726
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 26
social impact